VERA THERAPEUTICS INC. - CLASS A COMMON STOCK
42.26
06-January-25 16:45:00
15 minutes delayed
Stocks
-0.96
-2.22%
Today's range
41.57 - 43.76
ISIN
N/A
Source
NASDAQ
-
Vera Therapeutics to Host Business Update Call
17 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics to Participate in the 42nd Annual Cowen Health Care Conference
01 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
14 Feb 2022 16:01:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
10 Feb 2022 08:46:50 By Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock
07 Feb 2022 17:24:50 By Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Phase 3 Clinical Trial for Atacicept in Lupus Nephritis
18 Jan 2022 07:30:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 Jan 2022 07:30:01 By Nasdaq GlobeNewswire
-
17 Dec 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics Announces Appointment of Kimball Hall to Board of Directors
14 Dec 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics to Present at Upcoming Investment Conferences in November 2021
10 Nov 2021 16:15:01 By Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
10 Nov 2021 07:15:00 By Nasdaq GlobeNewswire
-
04 Nov 2021 16:05:01 By Nasdaq GlobeNewswire
-
13 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephropathy
09 Sep 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
16 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Vera Therapeutics Appoints Sean Grant as Chief Financial Officer
14 Jul 2021 07:30:00 By Nasdaq GlobeNewswire